Literature DB >> 10857823

Demarcation laser photocoagulation of selected macula-sparing rhegmatogenous retinal detachments.

T R Vrabec1, C R Baumal.   

Abstract

OBJECTIVE: To report a series of macula-sparing rhegmatogenous retinal detachments (MSRRDs) treated with demarcation laser photocoagulation (DLP).
DESIGN: Retrospective, noncomparative case series. PARTICIPANTS: Thirty-one patients (34 eyes) with primary or recurrent MSRRDs without associated visual field loss, necrotizing retinitis, or proliferative vitreoretinopathy (PVR), managed with DLP from November 1992 through May 1999. INTERVENTION: Demarcation laser photocoagulation consisting of a triple row of confluent laser burns. MAIN OUTCOME MEASURES: Best corrected postoperative visual acuity and MSRRD progression or recurrence.
RESULTS: Thirty-four primary and recurrent MSRRDs were treated by DLP, which consisted of a triple row of confluent laser burns. Macula-sparing rhegmatogenous retinal detachments were located in all quadrants and affected 10% to 45% of the retina. Findings associated with MSRRDs included lattice degeneration (12 eyes), vitreous hemorrhage (4 eyes), and demarcation line (9 eyes). Symptoms (photopsias or floaters) were associated with 14 MSRRDs. Eight eyes were myopic and 11 were pseudophakic. Thirty-two MSRRDs were shallow, two were dome shaped, and all were smooth without corrugations. Follow-up ranged from 1.5 to 80 months (mean, 15.8 months; median, 17 months). Thirty-three of 34 detachments remained stable after DLP. Three flattened spontaneously. One eye was managed with scleral buckle 6 weeks after DLP. Progression was attributed to incomplete laser treatment. Best corrected postoperative visual acuity was the same or improved in all but one eye, in which a cataract developed.
CONCLUSIONS: Demarcation laser photocoagulation is an effective method to manage acute or chronic, primary or recurrent MSRRDs without associated PVR that are shallow and smooth without corrugations. Demarcation laser photocoagulation is an alternative to both observation and surgical repair for these select MSRRDs.

Entities:  

Mesh:

Year:  2000        PMID: 10857823     DOI: 10.1016/s0161-6420(00)00091-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  Demarcation laser therapy in the management of macular-sparing persistent subretinal fluid after scleral buckling procedures.

Authors:  Yew Meng Wong; Noemi Lois
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-14       Impact factor: 3.117

2.  Management of a rhegmatogenous retinal detachment in a low-resource setting: treatment options when there is no vitreoretinal surgeon.

Authors:  Elizabeth Emsley; P J Steptoe; Sunildath Cazabon
Journal:  BMJ Case Rep       Date:  2018-03-28

3.  Differences in Vascular Density between Detached and Nondetached Areas in Eyes with Rhegmatogenous Retinal Detachment.

Authors:  Mariko Sato; Takeshi Iwase
Journal:  J Clin Med       Date:  2022-05-19       Impact factor: 4.964

4.  Pars plana vitrectomy for primary rhegmatogenous retinal detachment.

Authors:  Stephen G Schwartz; Harry W Flynn
Journal:  Clin Ophthalmol       Date:  2008-03

5.  Delayed macular hole formation after demarcation laser photocoagulation for subclinical retinal detachment.

Authors:  Irene M Rusu; Jessica Zizva; Jane S Myung; Kenneth Wald
Journal:  Clin Ophthalmol       Date:  2014-05-13

6.  Macula-Sparing Rhegmatogenous Retinal Detachment: Is Emergent Surgery Necessary?

Authors:  Sasan Mahmoudi; Arghavan Almony
Journal:  J Ophthalmic Vis Res       Date:  2016 Jan-Mar

7.  Changes in Retinal Vessel and Retinal Layer Thickness After Vitrectomy in Retinal Detachment via Swept-Source OCT Angiography.

Authors:  Eun Hee Hong; Heeyoon Cho; Du Roo Kim; Min Ho Kang; Yong Un Shin; Mincheol Seong
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.